Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial(legacy) | 145 |
| Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial(legacy) | 92 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial | 0 | 6 | 1 | 1 | 2 | 3 | 4 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 66 |
| China | 24 |
| Australia | 18 |
| Germany | 18 |
| Netherlands | 10 |
| Saudi Arabia | 5 |
| Vietnam | 5 |
| France | 4 |
| Brazil | 1 |
| Denmark | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 22 |
| Kaleen | 15 |
| Fairfield | 10 |
| Beijing | 8 |
| Rotterdam | 8 |
| Hanoi | 5 |
| Zhengzhou | 3 |
| Cambridge | 2 |
| Changchun | 2 |
| Des Moines | 2 |